Top 100 Companies in India

In terms of Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulations) read with Para A of Part A of Schedule III to the Regulations, Federal Bank has informed that Analyst/ Investor meet held today, December 18, 2025.

The above information is a part of company’s filings submitted to BSE.

Max Healthcare Institute has informed that the board of directors (Board) of the Company, at their meeting held today, December 18, 2025, have approved the proposal to enter into share purchase agreement (SPA) for acquisition of 100% equity stake in Yerawada Properties (YPPL), Pune, Maharashtra. The purchase of equity stake shall be carried out in a step-up manner and shall conclude upon receipt of Occupancy Certificate for the hospital building planned to be constructed on the said land. In the first tranche, the Company shall acquire 100% of the Class A equity shares representing 100% of the voting rights and ~50.22% of the economic interest in YPPL. Additionally, the Board has also accorded its approval for setting up a ~450 bedded super speciality hospital on the land owned by YPPL, at an aggregate spend of up to ?1,020 Crore (including YPPL shares acquisition, construction, equipment cost, stamp duty, registration charges, etc.). Details pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are enclosed as Annexure - I. The Board meeting commenced at 10.30 am (IST) and concluded at 10.55 am (IST). This disclosure will also be hosted on Company's website viz. www.maxhealthcare.in.

The above information is a part of company’s filings submitted to BSE.

Max Healthcare Institute has informed that the board of directors (Board) of the Company, at their meeting held today, December 18, 2025, have approved the proposal to enter into share purchase agreement (SPA) for acquisition of 100% equity stake in Yerawada Properties Private Limited (YPPL), Pune, Maharashtra. The purchase of equity stake shall be carried out in a step-up manner and shall conclude upon receipt of Occupancy Certificate for the hospital building planned to be constructed on the said land. In the first tranche, the Company shall acquire 100% of the Class A equity shares representing 100% of the voting rights and ~50.22% of the economic interest in YPPL. Additionally, the Board has also accorded its approval for setting up a ~450 bedded super speciality hospital on the land owned by YPPL, at an aggregate spend of up to ?1,020 Crore (including YPPL shares acquisition, construction, equipment cost, stamp duty, registration charges, etc.). Details pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are enclosed as Annexure - I. The Board meeting commenced at 10.30 am (IST) and concluded at 10.55 am (IST). This disclosure will also be hosted on Company's website viz. www.maxhealthcare.in

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Axis Bank has informed that based on the recommendations of the Nomination and Remuneration Committee, the Board of Directors at its meeting held on December 18, 2025, has appointed Malavika R. Harita (DIN: 09005600) as an additional independent director of the Bank for a period of four years with effect from December 18, 2025 up to December 17, 2029, subject to approval of shareholders. In terms of Section 149(13) of the Companies Act, 2013, she shall not be liable to retire by rotation during her tenure as an independent director of the Bank. Malavika R. Harita is not related to any of the Directors or Key Managerial Personnel of the Bank. Further, in line with the Stock Exchange Circular dated June 20, 2018, it has confirmed that she is not debarred from holding the office of director by virtue of any SEBI order or any other such authority. The Board Meeting commenced at 9.00 am and the said appointment was approved by the Board at 10.00 am. The details required as per SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, are enclosed as Annexure A.

The above information is a part of company’s filings submitted to BSE.